Fundraising Fox
🦊/Companies
Sign in

TeraPore Technologies

South San Francisco, US · Founded 2013 · Delaware corporation · 3 known investors

Find your way into TeraPore Technologies

366 people in our graph share verified history with the TeraPore Technologies team — schools, employers, funds. One of them is your warm intro.

Mike Zakunlockedknows Rachel M. Dorin · together at Cornell (overlapped)
×10knows the team · via Cornell
knows the team · via Sandia National Laboratories

TeraPore develops nanofiltration products based on self-assembled block copolymer membrane technology for critical separation applications, including virus filtration for therapeutic proteins and biologics and semiconductor manufacturing. Its IsoBlock VF product is an isoporous membrane designed for viral clearance across antibody constructs for biopharmaceutical manufacturers.

BiotechDeep TechNew Materials

Founders & leadership

TeraPore Technologies was founded in 2013 by Rachel M. Dorin.

RMRachel M. Dorin
Rachel M. DorininFounderRachel M. Dorin is Executive Officer and Director at TeraPore Technologies, where she leads development of nanofiltration products using self-assembled block copolymer membrane technology for applications including viral clearance in biopharmaceutical manufacturing and semiconductor processing.

Board

SB
Stuart BerkowitzBoard director
DS
David SeldinBoard directorManaging Partner at Anzu Partners
DM
David MichaelinBoard directorManaging Partner at Anzu Partners
MH
Mark HurwitzBoard director

Investors · 3

Anzu PartnersreportedBillerica
Artiman VenturesreportedPalo Alto · $2M – $6M
RA CapitalreportedBoston

Funding

SEC filings, press & company announcements

$13.5M disclosed across 3 rounds · 2016–2023

▶$1.8MraisedJan 2018 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stuart BerkowitzDirector
  • David SeldinDirector
  • Mark HurwitzDirector
  • David MichaelDirector
  • Rachel DorinExecutive Officer, Director
Offering amount
$4M
Amount sold
$1.8M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedJun 2016 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stuart BerkowitzDirector
  • David SeldinDirector
  • Rachel M. DorinExecutive Officer, Director
  • David MichaelDirector
  • Mark HurwitzDirector
Offering amount
$1.8M
Amount sold
$1.8M
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
PAREXEL3 shared keywordsParexel is a contract research organization (CRO) providing clinical development, regulatory consulting, and market access services for biopharmaceutical companies conducting clinical trials across phases I-IV globally. The company operates with a network of offices and specialized facilities across North America, Latin America, Europe, and Asia-Pacific.

Companies competing with TeraPore Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

TeraPore Technologies Raises $10M to Bring Precision Nanofiltration Solutions to New Marketssiliconvalleyjournals.com · Mar 2023TeraPore Technologies Raises $10M in Fundingfinsmes.com · Mar 2023TeraPore - Anzu Partners | Breakthrough Industrial and Life Sciences Technologiesanzupartners.com · Jul 2021TeraPore Technologies Raises $6M In Oversubscribed Series A Funding Round | Reutersreuters.com · Mar 2018

Frequently asked questions

What does TeraPore Technologies do?
TeraPore develops nanofiltration products based on self-assembled block copolymer membrane technology for critical separation applications, including virus filtration for therapeutic proteins and biologics and semiconductor manufacturing. Its IsoBlock VF product is an isoporous membrane designed for viral clearance across antibody constructs for biopharmaceutical manufacturers.
Who founded TeraPore Technologies?
TeraPore Technologies was founded by Rachel M. Dorin in 2013.
Who are TeraPore Technologies's investors?
TeraPore Technologies's investors include Anzu Partners, Artiman Ventures, RA Capital.
How much funding has TeraPore Technologies raised?
TeraPore Technologies has disclosed $13.5M raised across 3 rounds.
Where is TeraPore Technologies headquartered?
TeraPore Technologies is headquartered in South San Francisco, US.